Jazz Pharmaceuticals (JAZZ) Q3 2024 Earnings

Jul 31Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
2.68
3.55
4.43
5.3

Details

Expected EPS
4.922088
Actual EPS
5.3
Surprise EPS
0.38
Surprise Percent
+7.68%

Description

⁨Jazz Pharmaceuticals⁩ (⁦JAZZ⁩) has reported earnings of ⁦5.3⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts